Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-074 - Exosomal RNA-Profiling of Lung Pleural Effusions Identifies Adenocarcinoma Patients through Elevated miR-200 Expression
09:30 - 09:30 | Presenter: Per Hydbring | Author(s): L. De Petris, E. Branden, H. Koyi, M. Novak, L. Kanter, P. Hååg, J. Hurley, V. Tadigotla, J. Skog, K. Viktorsson, Simon Ekman, R. Lewensohn
- Abstract
Loading...
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-013 - Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): J. Remon, C. Nicotra, M. Noerholm, K. Brinkmann, David Planchard, C. Jovelet, E. Auclin, C. Flinspach, J. Hurley, J. Skog, A. Gazzah, C. Caramella, J. Adam, L. Lacroix, N. Auger, L. Friboulet, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
- Abstract
Loading...
-
+
P1.09 - Mesothelioma
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P1.09-012 - A Pre-Clinical Investigation of Intrapleural Curcumin Treatments as an Adjunct Therapy for Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Ashleigh Jean Hocking | Author(s): D. Elliot, J. Hua, M. Michael, S. Marri, Sonja Klebe
- Abstract
Loading...
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.07 - A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
11:40 - 11:45 | Presenter: Aaron Lisberg | Author(s): J. Hunt, N. Reese, T. Wang, P. Coluzzi, M. Spiegel, K. Bornazyan, J. Carroll, J. Madrigal, B. Ledezma, M. Mendenhall, J.L. Bui, H. Lu, A. Cummings, Z. Noor, Jonathan W. Goldman, Edward Brian Garon
- Abstract
Loading...
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-013 - Investigation of Genomic and TCR Repertoire Evolution of AAH, AIS, MIA to Invasive Lung Adenocarcinoma by Multiregion Exome and TCR Sequencing
09:30 - 09:30 | Presenter: Jianjun Zhang | Author(s): X. Hu, J. Fujimoto, L. Ying, A. Reuben, R. Chen, C. Chow, J. Rodriguez-Canales, W. Sun, J. Hu, E.R. Parra, B. Carmen, C. Wu, X. Mao, X. Song, J. Li, C. Gumbs, S.G. Swisher, J. Zhang, John V Heymach, W.K. Hong, Ignacio I. Wistuba, A. Futreal, D. Su
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-027 - Efficacy and Safety of Nivolumab Therapy for Advanced NSCLC in the Expanded Access Named Patient Program in Taiwan
09:30 - 09:30 | Presenter: Bin-Chi Liao | Author(s): C. Chiang, P. Chen, Y. Shen, W. Chen, J. Hung, K. Rau, C. Lai, C. Chen, Y. Kuo, Y. Tsai, S. Wu, C. Lin, Yu-Feng Wei, M. Wu, S. Tsao, T.C. Tsao, C. Ho, Y. Feng, C. Tsao, M. Lin, I. Chong, T. Hsia, N. Chu, Y. Chen, C. Yu, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.07-038 - Thyroid Dysfunction Arising During KEYNOTE-001 Associated with Improved Efficacy of Pembrolizumab in NSCLC Patients at UCLA
09:30 - 09:30 | Presenter: Aaron Lisberg | Author(s): K. Bornazyan, J. Madrigal, J.L. Bui, J. Carroll, C. Adame, J. Hunt, H. Lu, Z. Noor, A. Cummings, Jonathan W. Goldman, Edward Brian Garon
- Abstract
Loading...
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.06 - A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLC
11:55 - 12:05 | Presenter: Jin -Ji Yang | Author(s): Jian Fang, Y. Shu, J. Chang, G. Chen, J. He, W. Li, X. Liu, N. Yang, Caicun Zhou, J. Huang, L. Yang, A.A. Handzel, M.M. Frigault, G. Ahmed, C. Egile, S. Morgan, Yi-Long Wu
- Abstract
Loading...
-
+
MA 15 - Lung Cancer Biology II
- 15:45 - 17:30
- 10/17/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:H. Akita
-
+
MA 15.08 - Safety and Efficacy of Osimertinib in Treating an EGFR-Mutant Lung Cancer Patient with a Germline EGFR T790M Mutation
16:30 - 16:35 | Presenter: Tianhong Li | Author(s): W. Ma, J. Gong, J. Shan, D. Lewis, W. Xiao, J. Hung, E.H. Moore, Y. Zhang, N.Z. Mans, J. Welborn, K.S. Lam
- Abstract
Loading...
-
+
MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches
- 15:45 - 17:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:K. Shibuya, Francoise Mornex
